Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05617794 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Effect of Diffusion Optics Technology (DOT) Spectacle Lenses on Choroidal Thickness

Study acronym: ASH-2
StatusActive, Not Recruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Study completion date: Mar 31, 2026 to Dec 31, 2026v7
  2. Study completion date: May 15, 2024 to Mar 31, 2026v6
  3. Trial status: Recruiting to Active, Not Recruiting
    • Study completion date: May 15, 2023 to May 15, 2024
    • Site details revised
    v5
  4. Trial status: Not Yet Recruiting to Recruitingv4 Show 4 more changesShow less
    • Primary completion date: Mar 31, 2023 to Apr 30, 2023
    • Study completion date: Apr 15, 2023 to May 15, 2023
    • Start date changed from estimate of Dec 5, 2022 to Jan 18, 2023
    • Site details revised
  5. Primary endpoints revised (2)
    • Start date: Nov 14, 2022 to Dec 5, 2022
    • Secondary endpoint revised
    v3
  6. Re-verified, no change to tracked fieldsv2
  7. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The objective of the study is to measure the effect of Diffusion Optics Technology (DOT) spectacle lenses on the choroidal thickness and choroidal vascularity index compared to control lenses.
Trial Details
NCT Number NCT05617794
Lead Sponsor SightGlass Vision, Inc.
Collaborators: University of Waterloo
Conditions
(from sponsor)		 Myopia, Myopia Progression, Juvenile Myopia
Related terms Myopia
Enrollment 30 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov